<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30814282</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Hsp27 Responds to and Facilitates Enterovirus A71 Replication by Enhancing Viral Internal Ribosome Entry Site-Mediated Translation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e02322-18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02322-18</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) is a human pathogen that causes hand, foot, and mouth disease (HFMD) and fatal neurological diseases, and no effective treatment is available. Characterization of key host factors is important for understanding its pathogenesis and developing antiviral drugs. Here we report that Hsp27 is one of the most upregulated proteins in response to EV-A71 infection, as revealed by two-dimensional gel electrophoresis-based proteomics studies. Depletion of Hsp27 by small interfering RNA or CRISPR/Cas9-mediated knockout significantly inhibited viral replication, protein expression, and reproduction, while restoration of Hsp27 restored such virus activities. Furthermore, we show that Hsp27 plays a crucial role in regulating viral internal ribosome entry site (IRES) activities by two different mechanisms. Hsp27 markedly promoted 2A<sup>pro</sup>-mediated eukaryotic initiation factor 4G cleavage, an important process for selecting and initiating IRES-mediated translation. hnRNP A1 is a key IRES <i>trans</i>-acting factor (ITAF) for enhancing IRES-mediated translation. Surprisingly, knockout of Hsp27 differentially blocked hnRNP A1 but not FBP1 translocation from the nucleus to the cytoplasm and therefore abolished the hnRNP A1 interaction with IRES. Most importantly, the Hsp27 inhibitor 1,3,5-trihydroxy-13,13-dimethyl-2<i>H</i>-pyran [7,6-<i>b</i>] xanthone (TDP), a compound isolated from a traditional Chinese herb, significantly protected against cytopathic effects and inhibited EV-A71 infection. Collectively, our results demonstrate new functions of Hsp27 in facilitating virus infection and provide novel options for combating EV-A71 infection by targeting Hsp27.<b>IMPORTANCE</b> Outbreaks of infections with EV-A71, which causes hand, foot, and mouth disease, severe neurological disorders, and even death, have been repeatedly reported worldwide in recent decades and are a great public health problem for which no approved treatments are available. We show that Hsp27, a heat shock protein, supports EV-A71 infection in two distinct ways to promote viral IRES-dependent translation. A small-molecule Hsp27 inhibitor isolated from a traditional Chinese medicinal herb effectively reduces virus yields. Together, our findings demonstrate that Hsp27 plays an important role in EV-A71 infection and may serve as an antiviral target.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Dan et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dan</LastName><ForeName>Xuelian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Qianya</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Lina</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1122-6999</Identifier><AffiliationInfo><Affiliation>Guangdong Provincial Institution of Public Health, Guangdong Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Institution of Public Health, Guangdong Center for Disease Control and Prevention, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huangcan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hongxi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ming-Liang</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong mlhe7788@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CityU Shenzhen Research Institute, Shenzhen, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C113920">EIF4G1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039603">Eukaryotic Initiation Factor-4G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C057725">HSPB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076245">Heterogeneous Nuclear Ribonucleoprotein A1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067556">Internal Ribosome Entry Sites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.11</RegistryNumber><NameOfSubstance UI="C000630809">FBP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.11</RegistryNumber><NameOfSubstance UI="D006597">Fructose-Bisphosphatase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039603" MajorTopicYN="N">Eukaryotic Initiation Factor-4G</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006597" MajorTopicYN="N">Fructose-Bisphosphatase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="Y">Gene Expression Regulation, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076245" MajorTopicYN="N">Heterogeneous Nuclear Ribonucleoprotein A1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067556" MajorTopicYN="Y">Internal Ribosome Entry Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR/Cas9</Keyword><Keyword MajorTopicYN="N">IRES</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">heat shock protein 27</Keyword><Keyword MajorTopicYN="N">hnRNP A1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30814282</ArticleId><ArticleId IdType="pmc">PMC6475798</ArticleId><ArticleId IdType="doi">10.1128/JVI.02322-18</ArticleId><ArticleId IdType="pii">JVI.02322-18</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yi EJ, Shin YJ, Kim JH, Kim TG, Chang SY. 2017. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res 6:4&#x2013;14. doi:10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778&#x2013;790. doi:10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. 2010. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 9:1097&#x2013;1105. doi:10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. 1999. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341:936&#x2013;942. doi:10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129:304&#x2013;309. doi:10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Shih SR. 2013. Strategies to develop antivirals against enterovirus 71. Virol J 10:28. doi:10.1186/1743-422X-10-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-28</ArticleId><ArticleId IdType="pmc">PMC3614426</ArticleId><ArticleId IdType="pubmed">23339605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Chang HY, Lin PF, Chern JH, Hsu JT, Chang CY, Shih SR. 2009. Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother 53:2740&#x2013;2747. doi:10.1128/AAC.00101-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai FJ, Lin CW, Lai CC, Lan YC, Lai CH, Hung CH, Hsueh KC, Lin TH, Chang HC, Wan L, Sheu JJ, Lin YJ. 2011. Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem 128:312&#x2013;322. doi:10.1016/j.foodchem.2011.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2011.03.022</ArticleId><ArticleId IdType="pubmed">25212137</ArticleId></ArticleIdList></Reference><Reference><Citation>Too IHK, Bonne I, Tan EL, Chu JJH, Alonso S. 2018. Prohibitin plays a critical role in enterovirus 71 neuropathogenesis. PLoS Pathog 14:e1006778. doi:10.1371/journal.ppat.1006778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006778</ArticleId><ArticleId IdType="pmc">PMC5764453</ArticleId><ArticleId IdType="pubmed">29324904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Qi J, Chen Z, Xu X, Gao F, Lin D, Qian W, Liu H, Jiang H, Yan J, Gao GF. 2011. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol 85:10319&#x2013;10331. doi:10.1128/JVI.00787-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00787-11</ArticleId><ArticleId IdType="pmc">PMC3196414</ArticleId><ArticleId IdType="pubmed">21795339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Dong Q, Wang H, He Y, Chen Y, Zhang H, Wu R, Chen X, Zhou B, He J, Kung HF, Huang C, Wei Y, Huang JD, Xu H, He ML. 2016. Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57. Oncotarget 7:8797&#x2013;8808. doi:10.18632/oncotarget.7122.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.7122</ArticleId><ArticleId IdType="pmc">PMC4891005</ArticleId><ArticleId IdType="pubmed">26848777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KX, Ng MM, Chu JJ. 2010. Developments towards antiviral therapies against enterovirus 71. Drug Discov Today 15:1041&#x2013;1051. doi:10.1016/j.drudis.2010.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2010.10.008</ArticleId><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Stollar V, Li ML. 2011. Host factors in enterovirus 71 replication. J Virol 85:9658&#x2013;9666. doi:10.1128/JVI.05063-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05063-11</ArticleId><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Weng KF, Shih SR. 2012. Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol 7:467&#x2013;479. doi:10.2217/fmb.12.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.12.22</ArticleId><ArticleId IdType="pubmed">22439724</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. 2011. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37:313&#x2013;327. doi:10.3109/1040841X.2011.580723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2011.580723</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2012. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol 2:199&#x2013;205. doi:10.1016/j.coviro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Fujii K, Koike S. 2014. Receptors for enterovirus 71. Emerg Microbes Infect 3:e53. doi:10.1038/emi.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Shih SR. 2014. Update on enterovirus 71 infection. Curr Opin Virol 5:98&#x2013;104. doi:10.1016/j.coviro.2014.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CT, Kung YA, Li ML, Brewer G, Lee KM, Liu ST, Shih SR. 2016. Additive promotion of viral internal ribosome entry site-mediated translation by far upstream element-binding protein 1 and an enterovirus 71-induced cleavage product. PLoS Pathog 12:e1005959. doi:10.1371/journal.ppat.1005959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005959</ArticleId><ArticleId IdType="pmc">PMC5079569</ArticleId><ArticleId IdType="pubmed">27780225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KM, Chen CJ, Shih SR. 2017. Regulation mechanisms of viral IRES-driven translation. Trends Microbiol 25:546&#x2013;561. doi:10.1016/j.tim.2017.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2017.01.010</ArticleId><ArticleId IdType="pubmed">28242053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano G, Martinez-Salas E. 2015. Structural insights into viral IRES-dependent translation mechanisms. Curr Opin Virol 12:113&#x2013;120. doi:10.1016/j.coviro.2015.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2015.04.008</ArticleId><ArticleId IdType="pubmed">26004307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf BJ, Barton DJ. 2008. Poliovirus 2A(Pro) increases viral mRNA and polysome stability coordinately in time with cleavage of eIF4G. J Virol 82:5847&#x2013;5859. doi:10.1128/JVI.01514-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01514-07</ArticleId><ArticleId IdType="pmc">PMC2395153</ArticleId><ArticleId IdType="pubmed">18400852</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachims M, Van Breugel PC, Lloyd RE. 1999. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73:718&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC103879</ArticleId><ArticleId IdType="pubmed">9847378</ArticleId></ArticleIdList></Reference><Reference><Citation>Borman AM, Kirchweger R, Ziegler E, Rhoads RE, Skern T, Kean KM. 1997. eIF4G and its proteolytic cleavage products: effect on initiation of protein synthesis from capped, uncapped, and IRES-containing mRNAs. RNA 3:186&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369472</ArticleId><ArticleId IdType="pubmed">9042945</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SR, Sarnow P. 2003. Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology 315:259&#x2013;266. doi:10.1016/S0042-6822(03)00544-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00544-0</ArticleId><ArticleId IdType="pubmed">14592777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Lei X, Xiao X, Yang C, Lu W, Huang Z, Leng Q, Jin Q, He B, Meng G, Wang J. 2015. Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome. Cell Rep 12:42&#x2013;48. doi:10.1016/j.celrep.2015.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.05.047</ArticleId><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He YQ, Yi LN, Zan H, Kung HF, He ML. 2011. Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol 17:4135&#x2013;4142. doi:10.3748/wjg.v17.i36.4135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i36.4135</ArticleId><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Weng KF, Stollar V, Li ML. 2008. Viral protein synthesis is required for enterovirus 71 to induce apoptosis in human glioblastoma cells. J Neurovirol 14:53&#x2013;61. doi:10.1080/13550280701798980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280701798980</ArticleId><ArticleId IdType="pubmed">18300075</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86:3767&#x2013;3776. doi:10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Shih SR, Pan M, Li C, Lue CF, Stollar V, Li ML. 2009. hnRNP A1 interacts with the 5&#x2032; untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol 83:6106&#x2013;6114. doi:10.1128/JVI.02476-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02476-08</ArticleId><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu WM, Zhang JF, Wang H, Xi ZC, Wang WM, Zhuang P, Zhu X, Chen SC, Chan TM, Leung KS, Lu G, Xu HX, Kung HF. 2012. Heat shock protein 27 mediates the effect of 1,3,5-trihydroxy-13,13-dimethyl-2H-pyran [7,6-b] xanthone on mitochondrial apoptosis in hepatocellular carcinoma. J Proteomics 75:4833&#x2013;4843. doi:10.1016/j.jprot.2012.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2012.05.032</ArticleId><ArticleId IdType="pubmed">22677112</ArticleId></ArticleIdList></Reference><Reference><Citation>Jheng JR, Lau KS, Tang WF, Wu MS, Horng JT. 2010. Endoplasmic reticulum stress is induced and modulated by enterovirus 71. Cell Microbiol 12:796&#x2013;813. doi:10.1111/j.1462-5822.2010.01434.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2010.01434.x</ArticleId><ArticleId IdType="pubmed">20070307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S. 2017. Heat shock proteins and cancer. Trends Pharmacol Sci 38:226&#x2013;256. doi:10.1016/j.tips.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2016.11.009</ArticleId><ArticleId IdType="pubmed">28012700</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh MK, Sharma B, Tiwari PK. 2017. The small heat shock protein Hsp27: present understanding and future prospects. J Therm Biol 69:149&#x2013;154. doi:10.1016/j.jtherbio.2017.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtherbio.2017.06.004</ArticleId><ArticleId IdType="pubmed">29037376</ArticleId></ArticleIdList></Reference><Reference><Citation>Acunzo J, Katsogiannou M, Rocchi P. 2012. Small heat shock proteins HSP27 (HspB1), alphaB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol 44:1622&#x2013;1631. doi:10.1016/j.biocel.2012.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2012.04.002</ArticleId><ArticleId IdType="pubmed">22521623</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Jin F, Wang R, Li F, Wu Y, Kitazato K, Wang Y. 2017. HSP90: a promising broad-spectrum antiviral drug target. Arch Virol 162:3269&#x2013;3282. doi:10.1007/s00705-017-3511-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3511-1</ArticleId><ArticleId IdType="pubmed">28780632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewy TG, Grabowski JM, Bloom ME. 2017. BiP: master regulator of the unfolded protein response and crucial factor in flavivirus biology. Yale J Biol Med 90:291&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5482305</ArticleId><ArticleId IdType="pubmed">28656015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Yu J, Chan HL, Chen YC, Wang H, Chen Y, Chan CY, Go MY, Tsai SN, Ngai SM, To KF, Tong JH, He QY, Sung JJ, Kung HF, Cheng CH, He ML. 2009. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics 8:2582&#x2013;2594. doi:10.1074/mcp.M900180-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M900180-MCP200</ArticleId><ArticleId IdType="pmc">PMC2773723</ArticleId><ArticleId IdType="pubmed">19671925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew SS, Della Selva MP, Burch AD. 2009. Modification and reorganization of the cytoprotective cellular chaperone Hsp27 during herpes simplex virus type 1 infection. J Virol 83:9304&#x2013;9312. doi:10.1128/JVI.01826-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01826-08</ArticleId><ArticleId IdType="pmc">PMC2738236</ArticleId><ArticleId IdType="pubmed">19587060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreekanth GP, Chuncharunee A, Sirimontaporn A, Panaampon J, Noisakran S, Yenchitsomanus PT, Limjindaporn T. 2016. SB203580 modulates p38 MAPK signaling and dengue virus-induced liver injury by reducing MAPKAPK2, HSP27, and ATF2 phosphorylation. PLoS One 11:e0149486. doi:10.1371/journal.pone.0149486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0149486</ArticleId><ArticleId IdType="pmc">PMC4764010</ArticleId><ArticleId IdType="pubmed">26901653</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong SW, Yang YX, Hu HD, An X, Ye F, Ren H, Li SL, Zhang DZ. 2013. HSPB1 is an intracellular antiviral factor against hepatitis B virus. J Cell Biochem 114:162&#x2013;173. doi:10.1002/jcb.24313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.24313</ArticleId><ArticleId IdType="pubmed">22887120</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Q, Men R, Dan X, Chen Y, Li H, Chen G, Zee B, Wang MHT, He ML. 2018. Hsc70 regulates the IRES activity and serves as an antiviral target of enterovirus A71 infection. Antiviral Res 150:39&#x2013;46. doi:10.1016/j.antiviral.2017.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.11.020</ArticleId><ArticleId IdType="pubmed">29180285</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez O, Fontanes V, Raychaudhuri S, Loo R, Loo J, Arumugaswami V, Sun R, Dasgupta A, French SW. 2009. The heat shock protein inhibitor quercetin attenuates hepatitis C virus production. Hepatology 50:1756&#x2013;1764. doi:10.1002/hep.23232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23232</ArticleId><ArticleId IdType="pmc">PMC3846025</ArticleId><ArticleId IdType="pubmed">19839005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler E, Borman AM, Deliat FG, Liebig HD, Jugovic D, Kean KM, Skern T, Kuechler E. 1995. Picornavirus 2A proteinase-mediated stimulation of internal initiation of translation is dependent on enzymatic activity and the cleavage products of cellular proteins. Virology 213:549&#x2013;557. doi:10.1016/S0042-6822(95)90001-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(95)90001-2</ArticleId><ArticleId IdType="pubmed">7491779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt SL, Skern T, Liebig HD, Kuechler E, Jackson RJ. 1999. Rhinovirus 2A proteinase mediated stimulation of rhinovirus RNA translation is additive to the stimulation effected by cellular RNA binding proteins. Virus Res 62:119&#x2013;128. doi:10.1016/S0168-1702(99)00039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(99)00039-8</ArticleId><ArticleId IdType="pubmed">10507322</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan JL, Morley SJ. 2004. The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complex. Eur J Biochem 271:3596&#x2013;3611. doi:10.1111/j.0014-2956.2004.04306.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0014-2956.2004.04306.x</ArticleId><ArticleId IdType="pubmed">15317596</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighat A, Svitkin Y, Novoa I, Kuechler E, Skern T, Sonenberg N. 1996. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J Virol 70:8444&#x2013;8450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190934</ArticleId><ArticleId IdType="pubmed">8970966</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T, Bouhy D, Timmerman V. 2016. The hnRNP family: insights into their role in health and disease. Hum Genet 135:851&#x2013;867. doi:10.1007/s00439-016-1683-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccolo LL, Corona D, Onorati MC. 2014. Emerging roles for hnRNPs in post-transcriptional regulation: what can we learn from flies? Chromosoma 123:515&#x2013;527. doi:10.1007/s00412-014-0470-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00412-014-0470-0</ArticleId><ArticleId IdType="pubmed">24913828</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SG, Cheng ML, Chen KH, Horng JT, Liu CC, Wang SM, Sakurai H, Leu YL, Wang SD, Ho HY. 2017. Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo. Sci Rep 7:935. doi:10.1038/s41598-017-01110-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01110-x</ArticleId><ArticleId IdType="pmc">PMC5430552</ArticleId><ArticleId IdType="pubmed">28428548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolbert M, Morgan CE, Pollum M, Crespo-Hernandez CE, Li ML, Brewer G, Tolbert BS. 2017. HnRNP A1 alters the structure of a conserved enterovirus IRES domain to stimulate viral translation. J Mol Biol 429:2841&#x2013;2858. doi:10.1016/j.jmb.2017.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2017.06.007</ArticleId><ArticleId IdType="pmc">PMC5610934</ArticleId><ArticleId IdType="pubmed">28625847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CS, Seol SK, Song OK, Park JH, Jang SK. 2007. An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6, facilitate hepatitis C virus replication. J Virol 81:3852&#x2013;3865. doi:10.1128/JVI.01311-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01311-06</ArticleId><ArticleId IdType="pmc">PMC1866118</ArticleId><ArticleId IdType="pubmed">17229681</ArticleId></ArticleIdList></Reference><Reference><Citation>Monette A, Ajamian L, Lopez-Lastra M, Mouland AJ. 2009. Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J Biol Chem 284:31350&#x2013;31362. doi:10.1074/jbc.M109.048736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.048736</ArticleId><ArticleId IdType="pmc">PMC2781532</ArticleId><ArticleId IdType="pubmed">19737937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-G, Leu Y-L, Cheng M-L, Ting SC, Liu C-C, Wang S-D, Yang C-H, Hung C-Y, Sakurai H, Chen K-H, Ho H-Y. 2017. Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid. Sci Rep 7:12264. doi:10.1038/s41598-017-12388-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12388-2</ArticleId><ArticleId IdType="pmc">PMC5613005</ArticleId><ArticleId IdType="pubmed">28947773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>